Coronary artery disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• PCSK9 14
• SGLT2 12
• APOE 0
• GLP-1 4
• NLRP3 1
• PPAR 0
• IL-6 2
• NRF2 0
• CD40 0
• AKT 0
• VEGF 0
• TNF 1
• PI3K 0
• SIRT1 0
• TP53 0
• HMGB1 0
• STAT3 0
• TLR4 0
• HIF-1 0
• AMPK 0
• IL-1 1
• JAK 0
• MMP-9 0
• STING 1
• ERK 0
• GIP 1
• mTOR 0
• PD-1 0
• ACE2 0
• BDNF 0
• COX-2 0
• CXCR4 1
• DPP-4 0
• FGFR 0
• HER2 0
• IL-17 1
• MAPK 0
• PTEN 0
• TREM2 0
• YAP 0
• ABL1 0
• ALK 0
• ANGPTL3 0
• APP 0
• BACE1 0
• BCL-2 0
• BRAF 0
• BTK 0
• CCR5 0
• CGRP 0
• CTLA-4 0
• CTNNB1 0
• EZH2 0
• FOXP3 0
• FTO 0
• G6PD 0
• GPX4 0
• HSP90 0
• IL-4 1
• LRRK2 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents

  NCT06718179· Odense University Hospital· Updated 22 Oct 2026

  “Insufficient drug supply (prasugrel)”Registry text, quoted unchanged. Source

• Suspended

  Is Our Microbiome a Predictor of Cardiac Risk

  NCT02013284· Mayo Clinic· Updated 20 Oct 2026

  “Reorganizing study personnel and funding”Registry text, quoted unchanged. Source

• Terminated

  Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease

  NCT05147766· The Foundation for Orthopaedics and Regenerative Medicine· Updated 20 Oct 2026

  “Inadequate treatment response observed in preliminary data did not justify enrolling further study participants”Registry text, quoted unchanged. Source

• Withdrawn

  3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS

  NCT06409117· Konstantinos Toutouzas· Updated 19 Oct 2026

  “No funding”Registry text, quoted unchanged. Source

• Withdrawn

  Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL

  NCT07625306· Novartis Pharmaceuticals· Updated 14 Oct 2026

  “Study terminated by sponsor following the outcome of the Lp(a)HORIZON study (NCT04023552), which did not meet its primary endpoint”Registry text, quoted unchanged. Source

• Suspended

  IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

  NCT06071702· Medinol Ltd.· Updated 9 Oct 2026

  “Study was not initiated in any site. Sponsor decided not to start the study”Registry text, quoted unchanged. Source

• Suspended

  Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

  NCT07449325· VahatiCor, Inc.· Updated 25 Sept 2026

  “Study suspended to implement a protocol change”Registry text, quoted unchanged. Source

• Terminated

  YN001-004 in Patients With Coronary Atherosclerosis in Australia

  NCT06700720· Beijing Inno Medicine Co., Ltd.· Updated 23 Sept 2026

  “The study was terminated at the request of the Sponsor.”Registry text, quoted unchanged. Source

• Withdrawn

  Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease

  NCT06994624· Georgia State University· Updated 2 Sept 2026

  “Death of lead PI”Registry text, quoted unchanged. Source

• Withdrawn

  Comparative Outcomes of Mammary Artery Harvesting: Infection, Occlusion Rates and Thoracic Pain Assessment

  NCT07720661· Hamilton Health Sciences Corporation· Updated 28 Jul 2026

  “Registered too early. Completing the vanguard first which is registered separately.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

  NCT03892265· Washington University School of Medicine· Source

• The Bridging Antiplatelet Therapy With Cangrelor 2 Study

  NCT07225842· University of Florida· Source

• Thiamine Intervention and Coronary Artery Bypass Grafting

  NCT06326996· University of California, Los Angeles· Source

• Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG

  NCT07918781· China National Center for Cardiovascular Diseases· Source

• Physical Activity Intervention in ELderly Patients With Myocardial INfarction

  NCT04183465· University Hospital of Ferrara· Source

• CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes

  NCT04709900· Copenhagen University Hospital, Rigshospitalet· Source

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Novartis Pharmaceuticals· Source

• Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

  NCT06234410· University of Edinburgh· Source

• The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention

  NCT05677386· Copenhagen University Hospital, Rigshospitalet· Source

• Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation

  NCT07414966· China National Center for Cardiovascular Diseases· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 14
• Organoids 1
• Mendelian Randomization Analysis 136
• CRISPR-Cas Systems 4
• Gene Expression Profiling 48
• Sequence Analysis, RNA 2
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 68
• Metabolomics 41
• Mass Spectrometry 5
• Flow Cytometry 26
• Immunohistochemistry 12
• Positron-Emission Tomography 64
• Magnetic Resonance Imaging 66
• Machine Learning 159
• Deep Learning 85
• Cohort Studies 402
• Genome-Wide Association Study 163

• Network Pharmacology, Machine Learning, and Molecular Docking Analysis of Changluo Tiaogan Dinghun Decoction for Coronary Heart Disease with Anxiety.

  J Vis Exp, Nov 2026

• Machine-learning-integrated NLRC3 and cardiac troponin T dual-analyte lateral-flow biosensor for point-of-care acute coronary syndrome screening and acute myocardial infarction-unstable angina discrimination.

  Mikrochim Acta, Oct 2026

• Clinical Prediction Models in Elderly Acute Coronary Syndrome: A Bibliometric Analysis of Research Hotspots.

  Tissue Eng Part C Methods, Oct 2026

• Machine-Learning Prediction of Tumor Comorbidity and Cancer-Associated Mortality in Patients With Coronary Heart Disease: A 2-Stage Modeling Study.

  J Am Heart Assoc, Oct 2026

• Integrative Single-Cell Transcriptomics, Multi-Omics Analyses, and Computational Pharmacology Reveal Macrophage Heterogeneity and the Putative THBS1-CD36 Axis in Coronary Atherosclerosis.

  Chem Biol Drug Des, Oct 2026

• Coronary artery calcium score-emerging role for opportunistic screening on thoracic CT and novel applications.

  Br J Radiol, Oct 2026

• Calibrating Machine Learning Approaches for Probability Estimation Without Calibration Data.

  Stat Med, Oct 2026

• Multivariate Machine Learning Model for Long-Term Risk Prediction of Acute Coronary Syndrome in Patients With Heart Failure With Preserved Ejection Fraction and Obstructive Sleep Apnea.

  J Am Heart Assoc, Sept 2026

• Future promise, current clinical ambiguity: a systematic review of machine learning algorithm outputs predicting risk of cardiovascular disease.

  Open Heart, Sept 2026

• Machine learning-driven spleen imaging and genomics uncover a splenic connection to coronary artery disease.

  Sci Transl Med, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.